Axmed Scores $6M Grant From Gates Foundation For Medicine Access
🧬 Meet Axmed
-
Axmed helps low and middle income countries buy essential medications.
-
They just secured a $6 million grant to grow their B2B marketplace.
-
Investor check. The Bill & Melinda Gates Foundation provided the capital for this project.
🏥 Lowering Prices
-
People in developing regions are not accessible to life saving drugs because supply chains are broken.
-
Small markets often pay more for medications because they buy in low volumes.
-
Axmed fixes this by pooling demand from different countries into larger orders.
-
This aggregation gives healthcare providers the power to negotiate lower prices and more reliable delivery dates.
🤝 Direct Connections
-
The B2B marketplace links local healthcare providers directly with global manufacturers.
-
This setup removes unnecessary layers and bottlenecks from the procurement to logistics process.
-
The team built a system that handles complex regulatory rules and logistics across international borders.
🚀 Heading to New Markets
-
The new funds is set to be a long-term investment, allowing the team to focus on disciplined execution at scale.
-
They plan to strengthen procurement systems with AI, improve affordability with wider access to medicines.